ClinicalTrialsFinder

Myelodysplastic Syndrome With Excess Blasts Clinical Trials in Chicago, Illinois

1 recruitingChicago, Illinois

Showing 1–1 of 1 trials

Recruiting
Phase 1

TAK-243 in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndromes With Increased Blasts

Recurrent Myelodysplastic SyndromeRefractory Myelodysplastic SyndromeRecurrent Acute Myeloid Leukemia+4 more
National Cancer Institute (NCI)42 enrolled5 locationsNCT03816319